Richard S Geary Ionis Pharmaceuticals Inc (IONS) insider trading activity

Richard S Geary is EVP, Chief Development Officer of IONIS PHARMACEUTICALS INC. Currently has a direct ownership of 79,657 shares of IONS, which is worth approximately $5.82 Million. The most recent transaction as insider was on Aug 31, 2023, when has been sold 1 shares (Common Stock) at a price of $30.56 per share, resulting in proceeds of $30. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 79.7K

19.94% 3M change

6.1% 12M change

Total Value Held $5.82 Million

Richard S Geary Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 31 2023	BUY Other acquisition or disposition	$30 $30.56 p/Share	1 Added 0.0%	72,961 Common Stock
Feb 28 2023	BUY Other acquisition or disposition	$17,549 $30.52 p/Share	575 Added 0.78%	72,960 Common Stock
Feb 06 2023	SELL Open market or private sale	$78,067 $40.66 p/Share	1,920 Reduced 2.58%	72,385 Common Stock
Feb 03 2023	BUY Grant, award, or other acquisition	-	3,822 Added 4.89%	74,305 Common Stock
Jan 18 2023	SELL Open market or private sale	$311,534 $39.57 p/Share	7,873 Reduced 10.05%	70,483 Common Stock
Jan 17 2023	BUY Exercise of conversion of derivative security	-	21,983 Added 21.91%	78,356 Common Stock
Feb 28 2022	BUY Other acquisition or disposition	$17,618 $28.37 p/Share	621 Added 1.09%	56,373 Common Stock
Jan 18 2022	SELL Payment of exercise price or tax liability	$229,063 $30.12 p/Share	7,605 Reduced 12.0%	55,752 Common Stock
Jan 18 2022	BUY Exercise of conversion of derivative security	-	21,391 Added 25.24%	63,357 Common Stock
Aug 31 2021	BUY Other acquisition or disposition	$1,555 $33.8 p/Share	46 Added 0.11%	41,966 Common Stock
Feb 26 2021	BUY Other acquisition or disposition	$18,440 $44.54 p/Share	414 Added 0.98%	41,920 Common Stock
Jan 15 2021	SELL Payment of exercise price or tax liability	$392,069 $61.28 p/Share	6,398 Reduced 13.36%	41,506 Common Stock
Jan 15 2021	BUY Exercise of conversion of derivative security	-	17,598 Added 26.87%	47,904 Common Stock
Jan 13 2021	SELL Open market or private sale	$8,390 $59.5 p/Share	141 Reduced 0.46%	30,306 Common Stock
Nov 25 2020	SELL Open market or private sale	$596,596 $50.05 p/Share	11,920 Reduced 28.14%	30,447 Common Stock
Nov 25 2020	BUY Exercise of conversion of derivative security	$475,250 $39.87 p/Share	11,920 Added 21.96%	42,367 Common Stock
Nov 24 2020	SELL Open market or private sale	$120,975 $50.83 p/Share	2,380 Reduced 7.25%	30,447 Common Stock
Nov 24 2020	BUY Exercise of conversion of derivative security	$94,891 $39.87 p/Share	2,380 Added 6.76%	32,827 Common Stock
Nov 23 2020	SELL Open market or private sale	$536,177 $50.11 p/Share	10,700 Reduced 26.0%	30,447 Common Stock
Nov 23 2020	BUY Exercise of conversion of derivative security	$426,609 $39.87 p/Share	10,700 Added 20.64%	41,147 Common Stock

RSG

Richard S Geary

EVP, Chief Development Officer

Carlsbad, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IONS shares.

Notify only if

Value

Insider Trading

Get notified when an Ionis Pharmaceuticals Inc insider buys or sells IONS shares.

Notify only if

Operation

Value

Type

News

Receive news related to IONIS PHARMACEUTICALS INC

Track Activities on IONS

Account